Mary Penckofer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mary Penckofer has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- James Ernest Siegler
Department of Neurology, University of Chicago Medical Center, IL; and
3 shared publications - Mohamad Abdalkader
Boston Medical Center
2 shared publications - Savanna Dasgupta
Cooper Neurological Institute, Cooper University Hospital, Camden, NJ 08103, USA
2 shared publications - Shadi Yaghi
Department of Neurology, Rhode Island Hospital, Brown University, Providence, RI 02912, USA
2 shared publications - Thanh N. Nguyen
Department of Neurology, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118, USA
2 shared publications - Abigail Baldwin-LeClair
Cooper Medical School of Rowan University, Camden, NJ, USA
1 shared publication
Latest Publications
- 27 December 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 145, 111832
Impact of dehydration on functional outcomes in large vessel occlusion stroke
- 27 December 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 145, 111832
Impact of dehydration on functional outcomes in large vessel occlusion stroke
- Open Access
Cerebrovascular Disease in COVID-19
Not in the history of transmissible illnesses has there been an infection as strongly associated with acute cerebrovascular disease as the novel human coronavirus SARS-CoV-2. While the risk of stroke has known associations with other viral infections, such as influenza and human immunodeficiency virus, the risk of ischemic and hemorrhagic stroke related to SARS-CoV-2 is unprecedented. Furthermore, the coronavirus disease 2019 (COVID-19) pandemic has so profoundly impacted psychosocial behaviors and modern medical care that we have witnessed shifts in epidemiology and have adapted our treatment practices to reduce transmission, address delayed diagnoses, and mitigate gaps in healthcare. In this narrative review, we summarize the history and impact of the COVID-19 pandemic on cerebrovascular disease, and lessons learned regarding the management of patients as we endure this period of human history.
Open AccessCerebrovascular Disease in COVID-19
Not in the history of transmissible illnesses has there been an infection as strongly associated with acute cerebrovascular disease as the novel human coronavirus SARS-CoV-2. While the risk of stroke has known associations with other viral infections, such as influenza and human immunodeficiency virus, the risk of ischemic and hemorrhagic stroke related to SARS-CoV-2 is unprecedented. Furthermore, the coronavirus disease 2019 (COVID-19) pandemic has so profoundly impacted psychosocial behaviors and modern medical care that we have witnessed shifts in epidemiology and have adapted our treatment practices to reduce transmission, address delayed diagnoses, and mitigate gaps in healthcare. In this narrative review, we summarize the history and impact of the COVID-19 pandemic on cerebrovascular disease, and lessons learned regarding the management of patients as we endure this period of human history.
- Open Access
- 20 June 2023
- Published by MDPI AG in Preprints.org
Cerebrovascular Disease in COVID-19
Not in the history of transmissible illnesses has there been an infection as strongly associated with acute cerebrovascular disease as the novel human coronavirus, SARS-CoV-2. While the risk of stroke has known associations with other viral infections, such as influenza and human immunodeficiency virus, the risk of ischemic and hemorrhagic stroke related to SARS-CoV-2 is unprecedented. Furthermore, the coronavirus disease 2019 (COVID-19) pandemic has so profoundly impacted psychosocial behaviors and modern medical care that we have witnessed shifts in epidemiology and have adapted our treatment practices to reduce transmission, address delayed diagnoses, and mitigate gaps in health care. In this narrative review, we summarize the history and impact of the COVID-19 pandemic on cerebrovascular disease, and lessons learned regarding the management of patients as we endure this period of human history.
- 20 June 2023
- Published by MDPI AG in Preprints.org
Open AccessCerebrovascular Disease in COVID-19
Not in the history of transmissible illnesses has there been an infection as strongly associated with acute cerebrovascular disease as the novel human coronavirus, SARS-CoV-2. While the risk of stroke has known associations with other viral infections, such as influenza and human immunodeficiency virus, the risk of ischemic and hemorrhagic stroke related to SARS-CoV-2 is unprecedented. Furthermore, the coronavirus disease 2019 (COVID-19) pandemic has so profoundly impacted psychosocial behaviors and modern medical care that we have witnessed shifts in epidemiology and have adapted our treatment practices to reduce transmission, address delayed diagnoses, and mitigate gaps in health care. In this narrative review, we summarize the history and impact of the COVID-19 pandemic on cerebrovascular disease, and lessons learned regarding the management of patients as we endure this period of human history.
- Open Access
- 1 May 2023
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 3 (3)
Dissection Dilemma: Risk Stratification and Antithrombotic Selection
- 1 May 2023
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 3 (3)
Open AccessDissection Dilemma: Risk Stratification and Antithrombotic Selection